小胆管型原发性硬化性胆管炎的磁共振成像特征
研究纳入39例活检证实、诊断时MRCP(n=15)或ERCP(n=24)未见胆管异常的原发性硬化性胆管炎患者,评估MRI/MRCP表现并与15例正常对照比较。小胆管型PSC胆管树正常,但常见胆管周围强化、肝实质信号异常及肝门淋巴结增大,约三分之一随访进展为大管型PSC。
要点
- 小胆管型PSC胆管树可正常,但胆管周围强化、肝实质信号不均和肝门淋巴结增大常见。
- 动脉期胆管周围强化70%(7/10)、延迟期90%(9/10),T2WI肝实质信号不均53%(8/15)。
- 随访中8/24(33%)出现大管型PSC特征,10年累积进展率为8.5%。
关键影像表现/征象
- 基线MRCP组15例小胆管型PSC胆管树正常,但胆管较对照组有增大趋势。
- 胆管周围强化动脉期70%(7/10)、延迟期90%(9/10)。
- T2加权肝实质信号不均53%(8/15),增强后肝实质信号不均70%(7/10)。
- 肝门淋巴结增大73%(11/15)。
诊断标准与关键数值
- 小胆管型PSC定义为活检证实PSC且诊断时MRCP或ERCP无胆管异常。
- 随访出现大管型PSC特征者8/24(33%),10年累积进展率为8.5%。
临床应用与阅片要点
- 阅片时胆管树正常不能排除小胆管型PSC,应关注胆管周围强化、肝实质信号不均和肝门淋巴结增大。
- 小胆管型PSC随访中约三分之一进展为大管型PSC,随访MRCP需注意新出现的大胆管异常。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the biliary tree and hepatic parenchymal findings on magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) in small-duct primary sclerosing cholangitis (SD-PSC).
METHODS: Thirty-nine patients with biopsy-proven primary sclerosing cholangitis (PSC) without any bile duct abnormality on MRCP (n = 15) or ERCP (n = 24) at the time of diagnosis were identified. Follow-up MRCP was available in 36/39 patients (12/15 Baseline MRCP group and 24 Baseline ERCP group). Two radiologists in consensus assessed the MRI/MRCP findings. The baseline MRI/MRCP of 15 SD-PSC patients was compared with MRI/MRCP of 15 normal healthy potential liver donors (Control group). Comparisons were made between SD-PSC patients and the Control group, and between baseline and follow-up MRI/MRCP findings in the SD-PSC patients.
RESULTS: In the 15 Baseline MRCP SD-PSC subjects, the biliary tree was normal with a trend of larger bile ducts compared to the Control group. Periductal enhancement (arterial phase: 70%, 7/10; delayed phase: 90%, 9/10), heterogeneous parenchymal signal on T2-weighted (53%, 8/15) and post contrast-enhanced images (70%, 7/10), and enlarged periportal lymph nodes (73%, 11/15) were frequently present in patients with SD-PSC. Eight (33%) of 24 SD-PSC patients who had normal MRCP at baseline MRCP or initial follow-up MRCP after normal baseline ERCP showed large-duct PSC (LD-PSC) features on follow-up and the 10-year cumulative incidence for progression to LD-PSC rate was 8.5%.
CONCLUSION: SD-PSC patients have a normal biliary tree but frequently have peribiliary enhancement, abnormal parenchymal signal intensity, and periportal lymphadenopathy. One-third shows progression to LD-PSC on follow-up.
引用
- Kozaka K, Sheedy SP, Eaton JE, et al. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis. Abdom Radiol (NY). 2020. PMID: 32417935. doi:10.1007/s00261-020-02572-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。